JP2023546158A5 - - Google Patents
Info
- Publication number
- JP2023546158A5 JP2023546158A5 JP2023523535A JP2023523535A JP2023546158A5 JP 2023546158 A5 JP2023546158 A5 JP 2023546158A5 JP 2023523535 A JP2023523535 A JP 2023523535A JP 2023523535 A JP2023523535 A JP 2023523535A JP 2023546158 A5 JP2023546158 A5 JP 2023546158A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- nucleic acid
- guide molecule
- car
- molecule according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063093459P | 2020-10-19 | 2020-10-19 | |
| US63/093,459 | 2020-10-19 | ||
| US202063127648P | 2020-12-18 | 2020-12-18 | |
| US63/127,648 | 2020-12-18 | ||
| US202163229870P | 2021-08-05 | 2021-08-05 | |
| US63/229,870 | 2021-08-05 | ||
| PCT/US2021/055394 WO2022086846A2 (en) | 2020-10-19 | 2021-10-18 | Dna-containing polynucleotides and guides for crispr type v systems, and methods of making and using the same |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023546158A JP2023546158A (ja) | 2023-11-01 |
| JP2023546158A5 true JP2023546158A5 (https=) | 2023-11-09 |
| JP7698715B2 JP7698715B2 (ja) | 2025-06-25 |
Family
ID=78819995
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023523535A Active JP7698715B2 (ja) | 2020-10-19 | 2021-10-18 | Ｃｒｉｓｐｒ ｖ型系のためのｄｎａ含有ポリヌクレオチドおよびガイド、ならびにこれらを製造する方法および使用する方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250027078A1 (https=) |
| EP (1) | EP4229198A2 (https=) |
| JP (1) | JP7698715B2 (https=) |
| KR (1) | KR20230090337A (https=) |
| AU (1) | AU2021364314C1 (https=) |
| CA (1) | CA3198905A1 (https=) |
| IL (1) | IL302220A (https=) |
| MX (1) | MX2023004505A (https=) |
| WO (1) | WO2022086846A2 (https=) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110494559B (zh) * | 2017-03-28 | 2023-10-31 | 味之素株式会社 | 不分化地维持用培养基添加剂 |
| EP4508211A2 (en) * | 2022-04-13 | 2025-02-19 | Caribou Biosciences, Inc. | Therapeutic applications of crispr type v systems |
| WO2023225035A2 (en) * | 2022-05-16 | 2023-11-23 | Artisan Development Labs, Inc. | Compositions and methods for engineering cells |
| EP4504764A1 (en) | 2022-05-26 | 2025-02-12 | Caribou Biosciences, Inc. | Cytokine-receptor fusions for immune cell stimulation |
| WO2024046307A1 (zh) * | 2022-08-29 | 2024-03-07 | 北京迅识科技有限公司 | 一种突变的v型crispr酶及其应用 |
| AU2023353989A1 (en) | 2022-09-30 | 2025-02-27 | Caribou Biosciences, Inc. | Anti-ror1 chimeric antigen receptors (cars), cells expressing the cars and related methods |
| WO2024102434A1 (en) | 2022-11-10 | 2024-05-16 | Senda Biosciences, Inc. | Rna compositions comprising lipid nanoparticles or lipid reconstructed natural messenger packs |
| EP4584283A1 (en) | 2022-11-14 | 2025-07-16 | Caribou Biosciences, Inc. | Anti-cll-1 chimeric antigen receptors, engineered cells and related methods |
| AU2024236558A1 (en) | 2023-03-15 | 2025-10-09 | Renagade Therapeutics Management Inc. | Delivery of gene editing systems and methods of use thereof |
| EP4704886A1 (en) * | 2023-05-01 | 2026-03-11 | Caribou Biosciences, Inc. | Treatment of autoimmune diseases with bcma-targeting engineered immune cells |
| WO2025006880A1 (en) | 2023-06-29 | 2025-01-02 | Caribou Biosciences, Inc. | Diagnostic and therapeutic methods for use with ror1 antagonists |
| WO2025024679A1 (en) * | 2023-07-26 | 2025-01-30 | Caribou Biosciences, Inc. | In vitro validation methods for car-t cell therapies |
| AU2024335327A1 (en) | 2023-09-01 | 2026-03-26 | Renagade Therapeutics Management Inc. | Gene editing systems, compositions, and methods for treatment of vexas syndrome |
| WO2025117745A1 (en) | 2023-12-01 | 2025-06-05 | Caribou Biosciences, Inc. | Methods and compositions for improving precision of endonuclease-mediated genome editing |
| WO2025174765A1 (en) | 2024-02-12 | 2025-08-21 | Renagade Therapeutics Management Inc. | Lipid nanoparticles comprising coding rna molecules for use in gene editing and as vaccines and therapeutic agents |
| WO2025231432A1 (en) * | 2024-05-03 | 2025-11-06 | Caribou Biosciences, Inc. | In vivo gene editing with crispr systems |
| WO2026024468A1 (en) | 2024-07-26 | 2026-01-29 | Caribou Biosciences, Inc. | Modular linked chimeric antigen receptors |
| CN119881333B (zh) * | 2025-01-27 | 2025-11-28 | 上海市肿瘤研究所 | 一种dna纳米花级联crispr系统的蛋白标志物检测平台及其构建方法和应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9650617B2 (en) * | 2015-01-28 | 2017-05-16 | Pioneer Hi-Bred International. Inc. | CRISPR hybrid DNA/RNA polynucleotides and methods of use |
| EP3423580A1 (en) * | 2016-03-04 | 2019-01-09 | Editas Medicine, Inc. | Crispr-cpf1-related methods, compositions and components for cancer immunotherapy |
| CN105912952B (zh) * | 2016-05-04 | 2019-07-23 | 广州广电运通金融电子股份有限公司 | 一种基于Linux的注册表服务系统、方法及金融自助设备 |
| WO2017190664A1 (zh) * | 2016-05-05 | 2017-11-09 | 苏州吉玛基因股份有限公司 | 化学合成的crRNA和修饰crRNA在CRISPR/Cpf1基因编辑系统中的应用 |
| MX2018014993A (es) * | 2016-06-14 | 2019-09-06 | Pioneer Hi Bred Int | Uso de endonucleasa cpf1 para modificaciones de genoma de planta. |
| WO2018009822A1 (en) * | 2016-07-08 | 2018-01-11 | Ohio State Innovation Foundation | Modified nucleic acids, hybrid guide rnas, and uses thereof |
| EP3562942A4 (en) * | 2016-12-28 | 2020-12-09 | Ionis Pharmaceuticals, Inc. | MODIFIED CRISPR-RNA AND ITS USES |
| CN110616189B (zh) * | 2018-06-20 | 2022-02-18 | 西安桑尼赛尔生物医药有限公司 | 通用型靶向cd19抗原嵌合受体t细胞的制备及其应用 |
| WO2020007593A1 (en) * | 2018-07-02 | 2020-01-09 | Cellectis | Chimeric antigen receptors (car)-expressing cells and combination treatment for immunotherapy of patients with relapse refractory adverse genetic risk aml |
| PE20211959A1 (es) * | 2019-02-15 | 2021-09-30 | Editas Medicine Inc | Celulas asesinas naturales (nk) modificadas para inmunoterapia |
-
2021
- 2021-10-18 MX MX2023004505A patent/MX2023004505A/es unknown
- 2021-10-18 EP EP21816566.0A patent/EP4229198A2/en active Pending
- 2021-10-18 AU AU2021364314A patent/AU2021364314C1/en active Active
- 2021-10-18 JP JP2023523535A patent/JP7698715B2/ja active Active
- 2021-10-18 KR KR1020237016342A patent/KR20230090337A/ko active Pending
- 2021-10-18 CA CA3198905A patent/CA3198905A1/en active Pending
- 2021-10-18 IL IL302220A patent/IL302220A/en unknown
- 2021-10-18 WO PCT/US2021/055394 patent/WO2022086846A2/en not_active Ceased
- 2021-10-18 US US18/134,406 patent/US20250027078A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023546158A5 (https=) | ||
| AU2025271439A1 (en) | Chimeric antigen receptors based on single-domain antibodies and methods of use thereof | |
| AU2025205077A1 (en) | Methods for enhancing efficacy of therapeutic immune cells | |
| CN109485734B (zh) | 一种靶向bcma和cd19的双特异性嵌合抗原受体及其应用 | |
| CN107406518B (zh) | 嵌合抗原受体 | |
| AU2013295647B2 (en) | Multimeric fusion protein vaccine and immunotherapeutic | |
| KR20220111322A (ko) | 표적 rna를 편집하기 위한 기능성 영역을 부가한 안티센스형 가이드 rna | |
| AU2020230334A1 (en) | Compositions and methods for immunooncology | |
| JP2023515211A5 (https=) | ||
| JP2023516226A5 (https=) | ||
| FI3823665T3 (fi) | BCMA-spesifisiä kimeerisiä antigeenireseptoreita ja niiden käyttöjä | |
| JP2019525771A5 (https=) | ||
| CA2831294A1 (en) | Compositions and methods to immunize against hepatitis c virus | |
| WO2002032925A2 (en) | Protein scaffolds for antibody mimics and other binding proteins | |
| CN113840920A (zh) | 合并的敲入筛选和在内源基因座控制下共表达的异源多肽 | |
| JP2017537622A5 (https=) | ||
| CN115960264A (zh) | 转化生长因子-β应答多肽及其使用方法 | |
| JP2002508924A (ja) | エピトープへの結合能力を保持する結合部位ドメインの同定のための新規方法 | |
| JP2024519515A5 (https=) | ||
| CN113045657B (zh) | 一种人源化抗人bcma单克隆抗体及其car-t细胞 | |
| KR20230157387A (ko) | Cas 효소를 이용한 다중 편집 | |
| CN109844125A (zh) | 人pd-1基因敲除的cldn18．2特异性嵌合抗原受体t细胞的制备方法以及应用 | |
| WO2018041220A1 (zh) | 一种靶向人cd123的嵌合受体配体及其应用 | |
| CA3138991A1 (en) | Methods and compositions for diagnostically-responsive ligand-targeted delivery of therapeutic agents | |
| JP2025504898A5 (https=) |